LFST has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LFST has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, LifeStance Health Group's enterprise value is $2,975 Mil. LifeStance Health Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $1,056 Mil. Therefore, LifeStance Health Group's EV-to-Revenue for today is 2.82.
The historical rank and industry rank for LifeStance Health Group's EV-to-Revenue or its related term are showing as below:
During the past 5 years, the highest EV-to-Revenue of LifeStance Health Group was 26.54. The lowest was 2.16. And the median was 3.43.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2024-05-05), LifeStance Health Group's stock price is $6.66. LifeStance Health Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.87. Therefore, LifeStance Health Group's PS Ratio for today is 2.32.
The historical data trend for LifeStance Health Group's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
EV-to-Revenue | - | - | 5.35 | 2.59 | 3.22 |
LifeStance Health Group Quarterly Data | |||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
EV-to-Revenue | Get a 7-Day Free Trial | 2.59 | 3.52 | 4.03 | 3.03 | 3.22 |
For the Medical Care Facilities subindustry, LifeStance Health Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
LifeStance Health Group's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 2975.005 | / | 1055.665 | |
= | 2.82 |
LifeStance Health Group's current Enterprise Value is $2,975 Mil.
LifeStance Health Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,056 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group (NAS:LFST) EV-to-Revenue Explanation
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
LifeStance Health Group's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 6.66 | / | 2.873 | |
= | 2.32 |
LifeStance Health Group's share price for today is $6.66.
LifeStance Health Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.87.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of LifeStance Health Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Kevin Michael Mullins | officer: Chief Development Officer | 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251 |
Paula Cipollone | officer: See Remarks | 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251 |
Warren Gouk | officer: Chief Administrative Officer | 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251 |
Ann Varanakis | officer: Chief People Officer | 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251 |
Anisha Patel-dunn | officer: Chief Medical Officer | 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251 |
Ryan Pardo | officer: See Remarks | 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251 |
Danish J. Qureshi | officer: Chief Growth Officer | 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251 |
Pablo Pantaleoni | officer: Chief Digital Officer | 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251 |
David Bourdon | officer: Chief Financial Officer | 6303 COWBOYS WAY, SUITE 350, FRISCO TX 75034 |
Kenneth A Burdick | director, officer: Chief Executive Officer | 6705 ROCKLEDGE DR, SUITE 900, BETHESDA MD 20817 |
Felicia Gorcyca | officer: Chief People Officer | 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251 |
Michael K. Lester | director, officer: See Remarks | 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251 |
Gwen H. Booth | officer: Chief Operating Officer | 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251 |
Jesse Michael Bruff | officer: Chief Financial Officer | 3100 HANSEN WAY, PALO ALTO CA 94304 |
Tpg Gp A, Llc | 10 percent owner | 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102 |
From GuruFocus
By PRNewswire PRNewswire • 12-22-2022
By Marketwired • 09-21-2023
By Marketwired • 10-27-2023
By Marketwired • 08-09-2023
By Value_Insider Value_Insider • 10-18-2022
By Business Wire • 10-21-2023
By PRNewswire PRNewswire • 09-01-2022
By sperokesalga sperokesalga • 05-24-2023
By GuruFocus Research • 11-07-2023
By PRNewswire PRNewswire • 05-11-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.